Objective: To compare the effectiveness of two procedures increasing the botulinum toxin type A effect for wrist and finger flexor spasticity after stroke. Design: A single-blind randomized trial. Subjects: Seventy patients with upper limb post-stroke spasticity. Methods: Adults with wrist and finger flexor muscles spasticity after stroke were submitted to botulinum toxin type A therapy. After the treatment, the subjects injected were randomly divided into two groups and submitted to adhesive taping (Group A) or daily muscle manual stretching, passive articular mobilization of wrist and fingers, and palmar splint (Group B) for 10 days. We measured spasticity with Modified Ashworth Scale, related disability with Disability Assessment Scal...
Background: Botulinum toxin type A injection is widely used treatment option for the treatment of up...
QuestionDoes injection of Botulinum toxin followed by constraint-induced movement therapy improve sp...
Botulinum toxin type A (BTX-A) injections improve muscle tone and range of motion (ROM) among stroke...
Objective: To compare the effectiveness of two procedures increasing the botulinum toxin type A effe...
OBJECTIVE: To compare the effectiveness of two procedures increasing the botulinum toxin type A effe...
Background and objective: Spasticity is one of the problems following stroke. Due to this increase i...
This article is distributed under the terms of Creative Commons Attribution License which permits un...
Spasticity or increase in muscle tone is one of the problems following stroke. Due to this increase ...
Botulinum toxin type A is a first-line treatment for post-stroke focal spasticity, and the accuracy ...
Background: Spasticity is one of the problems after a stroke. Due to this increase in muscle tone, p...
Post-stroke spasticity (PS) occurs in most patients with stroke and contributes to the development o...
Botulinum toxin is effective in reducing spasticity post stroke. As there are limited data on post s...
To objectively quantify stiffness and clinical changes in the upper limb of poststroke patients foll...
OBJECTIVE: Spasticity is a common dysfunction in stroke patients. It hinders the performance of ever...
Rationale: Although clinical practice guidelines recommend that management of moderate to severe spa...
Background: Botulinum toxin type A injection is widely used treatment option for the treatment of up...
QuestionDoes injection of Botulinum toxin followed by constraint-induced movement therapy improve sp...
Botulinum toxin type A (BTX-A) injections improve muscle tone and range of motion (ROM) among stroke...
Objective: To compare the effectiveness of two procedures increasing the botulinum toxin type A effe...
OBJECTIVE: To compare the effectiveness of two procedures increasing the botulinum toxin type A effe...
Background and objective: Spasticity is one of the problems following stroke. Due to this increase i...
This article is distributed under the terms of Creative Commons Attribution License which permits un...
Spasticity or increase in muscle tone is one of the problems following stroke. Due to this increase ...
Botulinum toxin type A is a first-line treatment for post-stroke focal spasticity, and the accuracy ...
Background: Spasticity is one of the problems after a stroke. Due to this increase in muscle tone, p...
Post-stroke spasticity (PS) occurs in most patients with stroke and contributes to the development o...
Botulinum toxin is effective in reducing spasticity post stroke. As there are limited data on post s...
To objectively quantify stiffness and clinical changes in the upper limb of poststroke patients foll...
OBJECTIVE: Spasticity is a common dysfunction in stroke patients. It hinders the performance of ever...
Rationale: Although clinical practice guidelines recommend that management of moderate to severe spa...
Background: Botulinum toxin type A injection is widely used treatment option for the treatment of up...
QuestionDoes injection of Botulinum toxin followed by constraint-induced movement therapy improve sp...
Botulinum toxin type A (BTX-A) injections improve muscle tone and range of motion (ROM) among stroke...